Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
200 participants
OBSERVATIONAL
2023-11-10
2024-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Induced Trunk Extensors Fatigue on Balance and Lumbar Position Sense in Adolescents
NCT06852729
The Influence of BMI on Core Stability in Healthy Adults
NCT03756831
The Effect of Power Posing on Timed Up and Go Test Score
NCT03032393
Effects Of Posterior Oblique Sling Strengthening on Temporo-Spatial Gait Parameters in Young Adults
NCT06944769
Effect of Sequencing on Outcome Measures
NCT06445491
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I-Subjects:
200 adolescents from both sexes will be assigned to this study. They will be selected randomly from a secondary school student and first level university students. They will be selected according to the following criteria:
Inclusion criteria:
* Their age will be ranging from 16 to 18 years.
* The sample will be selected according to (BMI-for Age percentile) growth charts according to CDC (Centers for Disease Control and Prevention) (appendix-1) (NCHS, 2014)
* All participant will be free from any musculoskeletal deformities.
* All participant is free of peripheral neuropathic diseases.
* They have no visual or auditory or vestibular disorders.
* They will able to understand, follow and execute instructions included in the testing analysis procedures
They will be assigned into four group of equal numbers according to (BMI) body mass index for age percentile obese group (n=50), overweight group (n=50), underweight group (n=50) and normal group weight (n=50). They will be assigned as following:
Underweight group (A):
This group will be underweight group according to BMI- for age percentile growth chart ranged from BMI-for-age \< 5th percentiles.
Normal weight group (B):
This group will be with normal weight according to BMI- for age percentile growth chart which ranged from BMI-for-age 5th to 85th percentiles
Overweight group (C):
This group will be an overweight group according to BMI- for age percentile growth chart which ranged from BMI-for-age 85th to 95th percentiles
Obese group (D):
This group will be obese group according to BMI- for age percentile growth chart which ranged from BMI-for-age \> 95th percentiles and \<99th percentile
II-Instrumentations:
A) For selecting subjects:
Use the CDC (Centers for Disease Control and Prevention) growth charts for children and teens aged 2 through 20 years. Comparing body measurements with the appropriate age- and sex-specific growth chart enables health care providers to monitor growth and identify potential health- or nutrition-related problems. (NCHS/CDC, 2014)
B) For evaluation:
1\. Electronic body weight scale: for weight and Height measurements 2. Force platform: FREEMED platform and FREESTEP software (Sensor Medica, Inc., Via Umberto Agnelli 11, 00012 Guidonia Montecelio, Rome, Italy) were validated for both balance and gait analysis
III- Procedures:
For sample selection:
For subjects' selection use electronic body scale TCS-200-RT:
1. Weight
A platform electronic scale was used to determine weight (TCS-200-RT). The participants will wear minimum clothes (removed jacket, shoes, and jewelry), stand stationary in the middle of the scale's platform without touching anything, and their body weight will be evenly distributed on both feet
* A stadiometer (TCS-200-RT) with a vertical scale of 2 m and a sliding headpiece will be used to measure height to the closest 0.5 cm. The participants' heights will be measured without their shoes on. Participants will stand in the Frankfort horizontal plane The barefoot with eyes open. Initially they were instructed to stand relaxed with their feet separated at a comfortable width (about shoulder-width apart) and arms at sides in hanged position along the body and looking straight ahead and ankle-to-ankle angle 45° , and with the feet in a tandem position. The back of the head, heels, buttocks, and scapulae will be all against the vertical surface of the stadiometer.
Plate form method of analysis:
1. Testing procedures:
-The experiments will be conducted in a quiet room, the force platform will be positioned in the middle. During the static standing trial each subject will permitted to speak occasionally with a partner sitting or standing in front of him or her about 2 meters away at any subject chosen by him or her, the collected data during the 80 sec of the trials will be analyzed for a-p direction (COP a-p) and m-l direction (COP m-l)
-The test protocols usually include a Sensory Organization Test (SOT), During the test the subject is instructed to stand still and quietly with eyes open or closed depending on which of the six tests is being administered. The subject performs multiple trials per test .
the testing protocol is consisted of six trials: in the 1st trial is bilateral eye opened (EO) for 20 sec; in the 2nd trail is bilateral eye closed (EC) for 20 sec; in 3rd trial is unilateral RT leg with EO for 10 sec; in 4th trail is unilateral RT leg EC for 10 sec, in the 5th trail is unilateral LT leg with EO for 10 sec and in the 6th trail is unilateral LT leg EC for 10 sec. The total test duration is 80 sec
2. Testing parameters (outcomes):
The following parameters will be tested
1. Anteroposterior (AP) sway length rang of COP trajectory on (Y-Axis) (Delta Y).
2. Mediolateral (ML) sway length rang of COP trajectory on (x-Axis) (Delta X).
3. Average COP speed or velocity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Underweight group (A):
This group will be underweight group according to BMI- for age percentile growth chart ranged from BMI-for-age \< 5th percentiles.
No interventions assigned to this group
Normal weight group (B):
This group will be with normal weight according to BMI- for age percentile growth chart which ranged from BMI-for-age 5th to 85th percentiles
No interventions assigned to this group
Overweight group (C):
This group will be an overweight group according to BMI- for age percentile growth chart which ranged from BMI-for-age 85th to 95th percentiles
No interventions assigned to this group
Obese group (D):
This group will be obese group according to BMI- for age percentile growth chart which ranged from BMI-for-age \> 95th percentiles and \<99th percentile
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The sample will be selected according to (BMI-for Age percentile) growth charts according to CDC (Centers for Disease Control and Prevention)(NCHS, 2014)
* All participant will be free from any musculoskeletal deformities.
* All participant is free of peripheral neuropathic diseases.
* They have no visual or auditory or vestibular disorders.
* They will able to understand, follow and execute instructions included in the testing analysis procedures.
Exclusion Criteria
* All adolescent associated with any foot deformity.
* All adolescent had a previous foot orthopedic procedure.
* All adolescent has visual or auditory or vestibular disorder.
* All adolescent has peripheral neuropathy.
* Adolescent with morbid obesity BMI \>99th for age percentile
16 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Delta University for Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dina S. Noaman
demonstrator for pediatrics and its surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dina demonstrator for pediatrics and its surgery delta university, Bachelor
Role: PRINCIPAL_INVESTIGATOR
Delta University for Science and Technology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Delta university
Gamasa, Dakahlia Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Weight categories
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.